|
Volumn 36, Issue 3, 2002, Pages 687-691
|
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
LONG ACTING DRUG;
OCTREOTIDE;
PLACEBO;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HUMAN;
LIVER CELL CARCINOMA;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TUMOR REGRESSION;
|
EID: 0036725135
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2002.35071 Document Type: Article |
Times cited : (197)
|
References (22)
|